Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients

Blood

Volumn 91, Issue 12, 1998, Pages 4472-4479

  Maier Redelsperger, Micheline ^a   De Montalembert, Mariane ^b   Flahault, Antoine ^b   Neonato, Maria Grazia ^b   Ducrocq, Rolande ^b   Masson, Marie Pierre ^b   Girot, Robert ^b  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; BILIRUBIN; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMOLYSIS; HUMAN; LONG TERM CARE; MALE; NEUTROPHIL; OXYGEN SATURATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETICULOCYTE; SEX DIFFERENCE; SICKLE CELL ANEMIA;

EID: 0031809842     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4472.412k16_4472_4479     Document Type: Article

References (36)

1. Eaton WA, Hofrichter J: Sickle cell hemoglobin polymerization. Adv Protein Chem 40:819, 1990
2. Brittenham GM, Schechter AN, Noguchi CT: Hemoglobin S polymerization: Primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 65:183, 1985
3. Noguchi CT, Schechter AN, Rodgers GP: Sickle cell disease, in Higgs DR, Weatherall DJ (eds): Baillière's Clinical Haematology: The Haemoglobinopathies. London, UK, Baillièe Tindall, Saunders, 1993, p 57
4. Noguchi CT, Torchia DA, Schechter AN: Intracellular polymerization of sickle hemoglobin: Effects of cell heterogeneity. J Clin Invest 72:846, 1983
5. Poillon WN, Kim BC, Rodgers GP, Noguchi CT, Schechter AN: Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci USA 90:5039, 1993
6. Bookchin RM, Nagel RL, Balazs T: Role of hybrid tetramer formation in gelation of haemoglobin S. Nature 256:667, 1975
7. Sunshine HR, Hofrichter J, Eaton WA: Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins. J Mol Biol 133:435, 1979
8. Noguchi CT: Polymerization in erythrocytes containing S and non-S hemoglobins. Biophys J 45:1153, 1984
9. Schechter AN, Noguchi CT: Sickle hemoglobin polymer: Structure-function correlates, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 33
10. Orringer EP, Abraham DJ, Parker JC: Development of drug therapy, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 861
11. Rodgers GP: Pharmacologic modulation of fetal hemoglobin, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 829
12. Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G: Stimulation of F-cell production in patients with sickle cell anemia treated with cytarabine or hydroxyurea. N Engl J Med 313:1571, 1985
13. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
14. Triadou P, Maier-Redelsperger M, Krishnamoorthy R, Deschamps A, Casadevall N, Dunda O, Ducrocq R, Elion J, Girot R, Dover GJ, Cornu P: Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol 36:367, 1994
15. de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R, for the French Study Group on Sickle Cell Disease: Three years follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. J Pediatr Hematol Oncol 19:313, 1997
16. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schlechter AN, Nienhuis AW: Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 322:1037, 1990
17. Pic P, Ducrocq R, Girot R: Séparation des hémoglobines F, Fac, S, C, A1c et dosage de l'hémoglobine F par Chromatographie liquide haute performance. Ann Biol Clin 52:129, 1994
18. Maier-Redelsperger M, Noguchi CT, de Montalembert M, Rodgers GP, Schechter AN, Gourbil A, Blanchard D, Jais JP, Ducrocq R, Peltier JY, Cottat MC, Lacaille F, Belloy M, Elion J, Labié D, Girot R: Variation in fetal parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian prospective study on sickle cell disease. Blood 84:3182, 1994
19. Noguchi CT, Torchia DA, Schechter AN: Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation. Proc Natl Acad Sci USA 77:5487, 1980
20. Noguchi CT, Schechter AN: The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. Blood 58:1057, 1981
21. Schechter AN, Noguchi CT, Rodgers GP: Sickle cell disease, in Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus P (eds): Molecular Basis of Blood Diseases. Philadelphia, PA, Saunders, 1987, p 179
22. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D: Evidence for the multicentric origin of the Hb S gene in Africa. Proc Natl Acad Sci USA 81:1771, 1984
23. Chang YC, Maier-Redelsperger M, Smith KD, Contu L, Ducrocq R, de Montalembert M, Belloy M, Elion J, Dover GJ, Girot R: The relative importance of the X-linked FCP locus and β-globin haplotypes in determining haemoglobin F levels: A study of SS patients homozygous for βs haplotypes. Br J Haematol 96:806, 1997
24. Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ: Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 128:820, 1996
25. Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E: Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial. Blood 88:1960, 1996
26. Powars D, Chan LS, Schroeder WA: The variable expression of sickle cell disease is genetically determined. Semin Hematol 27:360, 1990
27. Steinberg MS, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ, and the Multicenter Study of Hydroxyurea: Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea. Blood 89:1078, 1997
28. Steinberg MH, Dreiling BL: Clinical, hematologic and biosynthetic studies in sickle cell-beta-thalassemia: A comparison with sickle cell anemia. Am J Hematol 1:35, 1976
29. Atlay C, Schroeder WA, Huisman THJ: The G gamma-delta-beta thalassemia and G gamma-beta-HPHF conditions in combination with beta-thalassemia and Hb-S. Am J Hematol 3:1, 1977
30. Powars D, Weirs JN, Chan LS, Schroeder WA: Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 63:921, 1984
31. Noguchi CT, Rodgers GP, Serjeant GR: Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 318:96, 1988
32. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
33. Bridges KR, Barabino GD, Brugnara C, Cho MR, Christoph GW, Dover GJ, Ewenstein BM, Golan DE, Guttmann CRC, Hofrichter J, Mulkern RV, Zhang B, Eaton WA: A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 88; 4701, 1996
34. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshby M, Milner PFA, Orringer EP, Phillips G, Platt OS, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
35. Sampietro M, Thein SW, Contreras M, Pazmany L: Variation of HbF and F-cell number with the G-γ XmnI (C-T) polymorphism in normal individuals. Blood 79:832, 1992
36. Merghoub T, Perichon B, Maier-Redelsperger M, Labie D, Feingold N, Dibenedetto SP, Samperi P, Schiliro G, Ducrocq R, Elion J, Krishnamoorthy R: Variation of fetal hemoglobin and F-cell number with the LCR-HS2 polymorphism in nonanemic individuals. Blood 88:2607, 1996